Compare · TMDX vs VRAY
TMDX vs VRAY
Side-by-side comparison of TransMedics Group Inc. (TMDX) and ViewRay Inc. (VRAY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TMDX and VRAY operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- TMDX is the larger of the two at $3.25B, about 4.5x VRAY ($726.7M).
- TMDX has hit the wire 5 times in the past 4 weeks while VRAY has been quiet.
- TMDX has more recent analyst coverage (19 ratings vs 9 for VRAY).
- Company
- TransMedics Group Inc.
- ViewRay Inc.
- Price
- $93.68+0.10%
- $0.03-39.95%
- Market cap
- $3.25B
- $726.7M
- 1M return
- +25.93%
- -
- 1Y return
- -18.71%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 5
- 0
- Recent ratings
- 19
- 9
TransMedics Group Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
ViewRay Inc.
ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
Latest TMDX
- Director Tobin James R gifted 18,000 shares (SEC Form 4)
- SEC Form 10-Q filed by TransMedics Group Inc.
- TransMedics Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- TransMedics Reports Second Quarter 2026 Financial Results
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
- UBS initiated coverage on TransMedics Group with a new price target
- TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
- Officer Corcoran Nicholas was granted 11,727 shares, increasing direct ownership by 39% to 41,558 units (SEC Form 4)
- Chief Financial Officer Hernandez Gerardo was granted 17,246 shares, increasing direct ownership by 117% to 31,935 units (SEC Form 4)
Latest VRAY
- SEC Form SC 13G/A filed by ViewRay Inc. (Amendment)
- SEC Form SC 13G/A filed by ViewRay Inc. (Amendment)
- SEC Form SC 13G/A filed by ViewRay Inc. (Amendment)
- NUBURU Appoints Brian Knaley as new CEO
- SEC Form 25-NSE filed by ViewRay Inc.
- ViewRay Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form NT 10-Q filed by ViewRay Inc.
- SEC Form SC 13G/A filed by ViewRay Inc. (Amendment)
- SEC Form 4 filed by Shah Sanket
- SEC Form 4 filed by Podbelski Adam Andrew